Regeneron Pharmaceuticals Inc (REGN)
701.85
-6.40
(-0.90%)
USD |
NASDAQ |
Dec 20, 16:00
707.00
+5.15
(+0.73%)
After-Hours: 20:00
Regeneron Pharmaceuticals Free Cash Flow: 3.319B for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen Inc | 6.283B |
| Eli Lilly and Co | -2.275B |
| Pfizer Inc | 8.227B |
| Biogen Inc | 1.768B |
| AbbVie Inc | 15.62B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.291B |
| Cash from Investing (Quarterly) | -574.40M |
| Cash from Financing (Quarterly) | -634.00M |
| Free Cash Flow Per Share (Quarterly) | 9.030 |
| Free Cash Flow to Equity (Quarterly) | 1.049B |
| Free Cash Flow to Firm (Quarterly) | 1.049B |
| Free Cash Flow Yield | 4.11% |